The spectrum of eye disease in hospitalized adults living with HIV, 1995-2010

AIDS Patient Care STDS. 2014 Feb;28(2):47-55. doi: 10.1089/apc.2013.0258. Epub 2014 Feb 3.

Abstract

Eye disease is a well-documented complication of HIV infection. Opportunistic infections generally comprised the majority of pre-antiretroviral therapy (ART) eye complications. With the introduction of ART, opportunistic infections diminished. However, early ART regimens were cumbersome regarding side effects and pill burden, making patient compliance difficult. Newer ART regimens are better tolerated and consist of fewer pills, theoretically making compliance easier and therapy more effective. The aim of this chart review study is to examine eye disease epidemiology in HIV patients as ART has evolved. We reviewed 222 admissions at Thomas Jefferson University Hospitals for 188 patients. These cases were divided into two groups. The first group was comprised of patients admitted from 1995 through 2003, while the second group consisted of patients admitted from 2003 to 2010. Eye disease epidemiology was compared between the two groups. Our study did note a significant decrease in eye diseases caused by opportunistic infections in the 2003-2010 patient group. Noninfectious eye disease is a significant complication in this group.

Publication types

  • Comparative Study

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / epidemiology*
  • Adult
  • Anti-Retroviral Agents / adverse effects
  • Anti-Retroviral Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Eye Diseases / diagnosis
  • Eye Diseases / drug therapy
  • Eye Diseases / epidemiology*
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Hospitalization / statistics & numerical data*
  • Humans
  • Incidence
  • Inpatients / statistics & numerical data*
  • Male
  • Middle Aged
  • Patient Compliance
  • Retrospective Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Viral Load

Substances

  • Anti-Retroviral Agents